Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Robert
Perez, EVP and COO, will present on Thursday, September 4th
at 2:40 P.M. EDT, at the Thomas Weisel Partners Healthcare Conference
being held at the Four Seasons Hotel in Boston. On Wednesday, September
24th at 4:00 P.M. EDT, David McGirr, SVP and
CFO, will present at the 2008 UBS Global Life Sciences Conference being
held at the Grand Hyatt Hotel in New York City. These presentations will
include discussion of the company’s business
activities, financial outlook, and current news.
A live audio webcast of the Thomas Weisel presentation and a live audio
with slides webcast of the UBS presentation will be accessible through
Cubist’s website at www.cubist.com
in the Investor Relations Conference Calendar section. Both webcasts
will be available on Cubist’s website for a
period of 30 days after the presentations.
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on
the research, development, and commercialization of pharmaceutical
products that address unmet medical needs in the acute care environment.
Cubist developed and commercialized CUBICIN®
(daptomycin for injection), a Gram-positive first-in-class
lipopeptide antibiotic. In the U.S. Cubist also promotes MERREM®
I.V. (meropenem for injection), Astra Zeneca’s
established broad spectrum (carbapenem class) I.V. antibiotic. The
Cubist product pipeline includes ecallantide, a recombinant human
protein in Phase 2 clinical trials for the prevention of blood loss
during cardiothoracic surgery, and pre-clinical programs that address
unmet medical needs in Gram-positive infections, Gram-negative
infections, CDAD (Clostridium difficile-associated diarrhea), and
HCV (Hepatitis C infections). Cubist is headquartered in Lexington, MA.
Additional information can be found at Cubist’s
web site at www.cubist.com.
Cubist and CUBICIN are registered trademarks of Cubist Pharmaceuticals,
Inc.
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior
Director, Corporate Communications
eileen.mcintyre@cubist.com
